These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 39126109)

  • 1. The Beneficial Effect of the SGLT2 Inhibitor Dapagliflozin in Alleviating Acute Myocardial Infarction-Induced Cardiomyocyte Injury by Increasing the Sirtuin Family SIRT1/SIRT3 and Cascade Signaling.
    Lin YH; Tsai WC; Chiu CC; Chi NY; Liu YH; Huang TC; Wu WT; Lin TH; Lai WT; Sheu SH; Hsu PC
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapagliflozin Alleviates Myocardial Ischaemia Reperfusion Injury by Activating Mitophagy
    Zuo W; Wang L; Tian R; Wang L; Liu Y; Qian H; Yang X; Liu Z
    Curr Vasc Pharmacol; 2024; 22(3):203-217. PubMed ID: 38141195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
    Arow M; Waldman M; Yadin D; Nudelman V; Shainberg A; Abraham NG; Freimark D; Kornowski R; Aravot D; Hochhauser E; Arad M
    Cardiovasc Diabetol; 2020 Jan; 19(1):7. PubMed ID: 31924211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury.
    Lahnwong C; Palee S; Apaijai N; Sriwichaiin S; Kerdphoo S; Jaiwongkam T; Chattipakorn SC; Chattipakorn N
    Cardiovasc Diabetol; 2020 Jun; 19(1):91. PubMed ID: 32539724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriate Dose of Dapagliflozin Improves Cardiac Outcomes by Normalizing Mitochondrial Fission and Reducing Cardiomyocyte Apoptosis After Acute Myocardial Infarction.
    Fan ZG; Xu Y; Chen X; Ji MY; Ma GS
    Drug Des Devel Ther; 2022; 16():2017-2030. PubMed ID: 35789742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirt1 promotes autophagy and inhibits apoptosis to protect cardiomyocytes from hypoxic stress.
    Luo G; Jian Z; Zhu Y; Zhu Y; Chen B; Ma R; Tang F; Xiao Y
    Int J Mol Med; 2019 May; 43(5):2033-2043. PubMed ID: 30864731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dapagliflozin prevents ERK activation and SGLT2-dependent endoglin upregulation in a mechanically provoked cardiac injury model.
    Yeh TC; Wu YC; Wong TY; Sun GC; Tseng CJ; Cheng PW
    Physiol Rep; 2024 Apr; 12(7):e15990. PubMed ID: 38575554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SGLT2 inhibitor Dapagliflozin alleviates cardiac dysfunction and fibrosis after myocardial infarction by activating PXR and promoting angiogenesis.
    Wang M; Liu X; Ding B; Lu Q; Ma J
    Biomed Pharmacother; 2024 Aug; 177():116994. PubMed ID: 38889638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury.
    Chang YK; Choi H; Jeong JY; Na KR; Lee KW; Lim BJ; Choi DE
    PLoS One; 2016; 11(7):e0158810. PubMed ID: 27391020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium.
    Cappetta D; De Angelis A; Ciuffreda LP; Coppini R; Cozzolino A; Miccichè A; Dell'Aversana C; D'Amario D; Cianflone E; Scavone C; Santini L; Palandri C; Naviglio S; Crea F; Rota M; Altucci L; Rossi F; Capuano A; Urbanek K; Berrino L
    Pharmacol Res; 2020 Jul; 157():104781. PubMed ID: 32360273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapagliflozin attenuates AKI to CKD transition in diabetes by activating SIRT3/PGC1-α signaling and alleviating aberrant metabolic reprogramming.
    Li H; Xia Y; Zha H; Zhang Y; Shi L; Wang J; Huang H; Yue R; Hu B; Zhu J; Song Z
    Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167433. PubMed ID: 39067538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats.
    Durak A; Olgar Y; Degirmenci S; Akkus E; Tuncay E; Turan B
    Cardiovasc Diabetol; 2018 Nov; 17(1):144. PubMed ID: 30447687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dapagliflozin dampens liver fibrosis induced by common bile duct ligation in rats associated with the augmentation of the hepatic Sirt1/AMPK/PGC1α/FoxO1 axis.
    Hassan HA; Nageeb MM; Mohammed HO; Samy W; Fawzy A; Afifi R; Abbas NAT
    Toxicol Appl Pharmacol; 2024 Aug; 489():116991. PubMed ID: 38871090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dapagliflozin Attenuates Cardiac Remodeling in Mice Model of Cardiac Pressure Overload.
    Shi L; Zhu D; Wang S; Jiang A; Li F
    Am J Hypertens; 2019 Apr; 32(5):452-459. PubMed ID: 30689697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling.
    Zhang Y; Lin X; Chu Y; Chen X; Du H; Zhang H; Xu C; Xie H; Ruan Q; Lin J; Liu J; Zeng J; Ma K; Chai D
    Cardiovasc Diabetol; 2021 Jun; 20(1):121. PubMed ID: 34116674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol Upregulates Cardiac SDF-1 in Mice with Acute Myocardial Infarction through the Deacetylation of Cardiac p53.
    Hong W; Tatsuo S; Shou-Dong W; Qian Z; Jian-Feng H; Jue W; Chen J; Hai-Yan Q; Yue-Jin Y
    PLoS One; 2015; 10(6):e0128978. PubMed ID: 26053177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced
    Hodrea J; Balogh DB; Hosszu A; Lenart L; Besztercei B; Koszegi S; Sparding N; Genovese F; Wagner LJ; Szabo AJ; Fekete A
    Am J Physiol Renal Physiol; 2020 Apr; 318(4):F1017-F1029. PubMed ID: 32116017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyroptosis inhibitors MCC950 and VX-765 mitigate myocardial injury by alleviating oxidative stress, inflammation, and apoptosis in acute myocardial hypoxia.
    Ye X; Lin ZJ; Hong GH; Wang ZM; Dou RT; Lin JY; Xie JH; Shen YW
    Exp Cell Res; 2024 May; 438(2):114061. PubMed ID: 38692345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polydatin protects cardiomyocytes against myocardial infarction injury by activating Sirt3.
    Zhang M; Zhao Z; Shen M; Zhang Y; Duan J; Guo Y; Zhang D; Hu J; Lin J; Man W; Hou L; Wang H; Sun D
    Biochim Biophys Acta Mol Basis Dis; 2017 Aug; 1863(8):1962-1972. PubMed ID: 27613967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct cardio-protection of Dapagliflozin against obesity-related cardiomyopathy via NHE1/MAPK signaling.
    Lin K; Yang N; Luo W; Qian JF; Zhu WW; Ye SJ; Yuan CX; Xu DY; Liang G; Huang WJ; Shan PR
    Acta Pharmacol Sin; 2022 Oct; 43(10):2624-2635. PubMed ID: 35217813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.